Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
March 11, 2015
AgeneBio CEO Says Delays in Alzheimer’s Onset Could Save Millions, As Paradigm Shifts
Recent data published by the National Institutes on Aging show that modest delays in the onset of Alzheimer’s related dementia have massive benefits to patients, their families and society as a whole, the CEO of a company creating a new drug for the disease told BioSpace (DHX), and scientists should focus more on this important link.
